AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15845566
Drug: Recommended regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommended regimen (Gemcitabine 1000 mg/m(2) on days 1 and 8 plus docetaxel 50 mg/m(2) on day 8)
Trial: 10609423
Drug: Family-focused psychoeducational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-focused psychoeducational therapy (FFT)
Trial: 8690106
Drug: Goserelin acetate
RxNorm normalized name: Goserelin Acetate
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Goserelin acetate 3.6 mg once monthly plus 600 mg/d iron
Trial: 8690106
Drug: Goserelin acetate
RxNorm normalized name: Goserelin Acetate
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Goserelin acetate 3.6 mg once monthly plus placebo iron
Trial: 8690106
Drug: Iron alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron alone (600 mg/d)
Trial: 6370482
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tablets
Trial: 6370482
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg tablets
Trial: 6370482
Drug: 2% suspension
RxNorm normalized name: Top Cat 2.2% Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% suspension
Trial: 24791343
Drug: Sertaconazole 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertaconazole 2% cream
Trial: 30264179
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) applied to the quadriceps muscle (850 nm, 5 J per diode)
Trial: 24124921
Drug: Intralesional verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional verapamil (ILV) 10 mg weekly for 12 weeks
Trial: 24124921
Drug: Intralesional verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional verapamil (ILV) 10 mg weekly for 12 weeks + oral antioxidants (one tablet once a day for 3 months)
Trial: 24124921
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ILV monotherapy)
Trial: 20237064
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg beta-carotene
Trial: 20237064
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg beta-carotene
Trial: 17334775
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg propranolol non-competitive (betaNon)
Trial: 7624490
Drug: Butocamide hydrogen
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butocamide hydrogen succinate (BAHS) 600 mg
Trial: 7624490
Drug: BAHS 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAHS 600 mg + Nitrazepam 5 mg
Trial: 2196359
Drug: Captopril (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (0.9 mg/kg/day)
Trial: 359752
Drug: Intramuscular benzathine
RxNorm normalized name: Cephapirin Benzathine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular benzathine penicillin G alone
Trial: 359752
Drug: Intramuscular benzathine
RxNorm normalized name: Cephapirin Benzathine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular benzathine penicillin G combined with hexachlorophene scrubbing
Trial: 30669618
Drug: EGCG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGCG treatment
Trial: 29129251
Drug: Edoxaban 60
RxNorm normalized name: edoxaban 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 60 mg (or 30 mg for specific conditions)
Trial: 29129251
Drug: Edoxaban and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban and Enoxaparin-warfarin
Trial: 10991842
Drug: saquinavir-SGC (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saquinavir-SGC (1,200 to 1,800 mg) plus ritonavir (100 to 200 mg)
Trial: 10991842
Drug: saquinavir-SGC (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saquinavir-SGC (1,200 mg) three times daily
Trial: 28506446
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D treatment
Trial: 8969617
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy and bisphosphonates
Trial: 3993612
Drug: Nutrient-rich dietary
RxNorm normalized name: Votrient
DrugBank: Pazopanib (DB06589)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Nutrient-rich dietary supplement (group A)
Trial: 23908187
Drug: FIN-RACo+INFL (infliximab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FIN-RACo+INFL (infliximab 3 mg/kg)
Trial: 22749176
Drug: Cinnamon extract
RxNorm normalized name: Cinnamon Extract
DrugBank: Chinese cinnamon (DB16593)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnamon extract (low-dose at 120 mg/d)
Trial: 22749176
Drug: Cinnamon extract
RxNorm normalized name: Cinnamon Extract
DrugBank: Chinese cinnamon (DB16593)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnamon extract (high-dose at 360 mg/d)
Trial: 20414661
Drug: Disimpaction for
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disimpaction for the first week and daily laxative (Group A1)
Trial: 20414661
Drug: Only daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only daily laxative (Group A2)
Trial: 20414661
Drug: Disimpaction for
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disimpaction for the first week and daily laxative (Group B1)
Trial: 20414661
Drug: Only daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only daily laxative (Group B2)
Trial: 18689552
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (6 g of ALA)
Trial: 18689552
Drug: Milled flaxseed
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milled flaxseed (30 g)
Trial: 18689552
Drug: Whole flaxseed
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole flaxseed (30 g)
Trial: 16422825
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg on-demand treatment
Trial: 16422825
Drug: Tadalafil 3
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil 3 times/week treatment
Trial: 15540759
Drug: Doxazosin 8
RxNorm normalized name: doxazosin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin 8 mg with Tadalafil 20 mg
Trial: 15540759
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg with Tadalafil 10 mg
Trial: 15540759
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg with Tadalafil 20 mg
Trial: 24935082
Drug: Medication management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication management plus CBT
Trial: 22874692
Drug: Transdermal diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal diclofenac
Trial: 11341172
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of anti-insulin antibodies (AB1)
Trial: 11341172
Drug: Elevated levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated levels of antiidiotypic antibodies (AIAb2)
Trial: 11341172
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of anti-insulin/NGF Ab1
Trial: 30440913
Drug: 1Hz rTMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1Hz rTMS treatment 4 days/week for 3 weeks followed by 30min occupational therapy (OT)
Trial: 26784537
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (CBT) for aggression, 12 sessions
Trial: 19093057
Drug: Metronidazole plus
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole plus amoxicillin
Trial: 16280177
Drug: Foscarnet (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foscarnet (1 g/day for 4 weeks)
Trial: 10048641
Drug: Braun/Oral B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun/Oral B D7 powered toothbrush
Trial: 10048641
Drug: Oral B
RxNorm normalized name: bran ORAL BOX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral B Advantage B35 manual toothbrush
Trial: 2497168
Drug: Cromolyn sodium
RxNorm normalized name: Cromolyn Sodium
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium (10 mg)
Trial: 2134003
Drug: Beveled preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beveled preparations
Trial: 2134003
Drug: Non-beveled preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-beveled preparations
Trial: 30557080
Drug: Simultaneous steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous steroid injection after percutaneous A1 pulley release
Trial: 792640
Drug: Control (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (placebo or no treatment)
Trial: 8895711
Drug: Meperidine 100
RxNorm normalized name: meperidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 100 mg IM intraoperative preprocedure
Trial: 8895711
Drug: Meperidine 100
RxNorm normalized name: meperidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 100 mg IM intraoperative postprocedure
Trial: 8895711
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine 60 mg IM intraoperative preprocedure
Trial: 8895711
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine 60 mg IM postprocedure
Trial: 6343155
Drug: Flurbiprofen 300
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 300 mg/day
Trial: 3291099
Drug: Naproxen 750
RxNorm normalized name: naproxen 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 750 mg/day
Trial: 29394211
Drug: Other Nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other Nerve Stimulation Therapies (NSTs)
Trial: 29394211
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (sham, placebo, or medication only)
Trial: 25345982
Drug: RIF‐MMX (2×200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIF‐MMX (2×200 mg twice daily for 3 days)
Trial: 15901742
Drug: Progesterone cream
RxNorm normalized name: NATURAL PROGESTERONE CREAM,TOP
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone cream 40 mg twice daily for 12 days
Trial: 15901742
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone capsules 200 mg once daily for 12 days
Trial: 12556074
Drug: Low calcium
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calcium dialysate (1.25 mmol/L calcium)
Trial: 12556074
Drug: Standard dialysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dialysate (1.75 mmol/L calcium)
Trial: 2291881
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of 0.25% bupivacaine plain
Trial: 2291881
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of 0.25% bupivacaine with epinephrine 1:200,000
Trial: 30106523
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health promotion program in primary schools
Trial: 30106523
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health promotion program in primary schools (for high socio-economic status)
Trial: 30106523
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health promotion program in primary schools (for low socio-economic status)
Trial: 26872721
Drug: Chicory inulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chicory inulin (10g daily for 2 months)
Trial: 22180317
Drug: Intense Pulsed
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intense Pulsed Light (IPL) treatment with a spectral range of 500-670 and 870-1,200 nm, fluence range of 34-70 J/cm(2), 10 mm × 15 mm spot, pulse width of 10 or 100 mseconds, and 5°C contact cooling.
Trial: 22180317
Drug: Pulsed Dye
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Dye Laser (PDL) treatment at 595 nm, fluence range of 8.1-14.5 J/cm(2), 10 or 7 mm spot, pulse width of 10 or 40 mseconds, with Zimmer air cooling and ultrasound gel.
Trial: 8576655
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of sodium cromoglycate
Trial: 2338416
Drug: FCE 22101
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FCE 22101 intravenously at a dose of 250 mg
Trial: 2338416
Drug: FCE 22891
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FCE 22891 orally at a dose of 500 mg
Trial: 24115827
Drug: LAM +
RxNorm normalized name: lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LAM + ADV therapy
Trial: 21887230
Drug: G‐CSF treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF treatment (2.5, 5, or 10 μg/kg body weight) for 5 consecutive days
Trial: 9692813
Drug: G‐CSF treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF treatment
Trial: 21887230
Drug: G‐CSF treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF treatment in combination with routine IV thrombolysis
Trial: 18719948
Drug: Nasal O2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal O2 insufflation (4 l/min)
Trial: 11563404
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ketoprofen administered locally
Trial: 11563404
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg ketoprofen administered locally
Trial: 11563404
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg oral capsule of ketoprofen
Trial: 11563404
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 10 mg ketoprofen
Trial: 7128191
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg meptazinol
Trial: 23306584
Drug: Low tidal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low tidal volume ventilation (≈3 ml/kg) combined with extracorporeal CO2 elimination
Trial: 23306584
Drug: ARDSNet strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARDSNet strategy (≈6 ml/kg) without the extracorporeal device
Trial: 17159021
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (twice‐weekly sessions of standard Swedish massage in weeks 1‐4 and once‐weekly sessions in weeks 5‐8)
Trial: 9059567
Drug: L-arginine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (30 g in 50 ml of normal saline over 30 minutes) with L-NAME (90 micrograms/kg in 50 ml of normal saline)
Trial: 9059567
Drug: Glucose (0.33
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (0.33 g/kg body weight in a bolus) with L-NAME (90 micrograms/kg in 50 ml of normal saline)
Trial: 9059567
Drug: Glucose (0.33
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (0.33 g/kg body weight in a bolus) with saline
Trial: 9059567
Drug: L-NAME (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME (90 micrograms/kg in 50 ml of normal saline) alone
Trial: 7956277
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion (5 micrograms/kg/min i.v.)
Trial: 2885637
Drug: Adjuvant tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant tamoxifen 20 mg daily for 5 years
Trial: 2885637
Drug: Tamoxifen for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen for the treatment of first relapse (Control)
Trial: 26386578
Drug: Intravenous MDCO-157
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous MDCO-157 75 mg
Trial: 26386578
Drug: Intravenous MDCO-157
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous MDCO-157 150 mg
Trial: 26386578
Drug: Intravenous MDCO-157
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous MDCO-157 300 mg
Trial: 26386578
Drug: Oral Clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Clopidogrel 300 mg
Trial: 20738314
Drug: Physiological sex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological sex steroid replacement (pSSR) - transdermal oestradiol 100 μg daily for week 1, 150 μg for weeks 2-4; vaginal progesterone 200 mg twice daily for weeks 3-4
Trial: 20738314
Drug: Standard hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard hormone replacement treatment (sHRT) - oral ethinyloestradiol 30 μg and 1.5 mg norethisterone daily for weeks 1-3, week 4 'pill-free'
Trial: 20738314
Drug: Standard hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard hormone replacement treatment (sHRT)
Trial: 2876508
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of SMS 201-995 at doses of 25, 50, 100, and 200 micrograms
Trial: 2876508
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration of SMS 201-995 at doses of 50, 100, 200, and 400 micrograms
Trial: 2876508
Drug: Both intravenous
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both intravenous and subcutaneous administration of SMS 201-995
Trial: 27267109
Drug: Physiotherapy informed
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapy informed by Acceptance and Commitment Therapy (PACT)
Trial: 9508225
Drug: IV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV therapy team
Trial: 14608565
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (Control)
Trial: 31541635
Drug: 3.6-mL 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6-mL 2% lidocaine intracervical block
Trial: 31541635
Drug: Sham injection
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham injection (intracervical dry-needling)
Trial: 28370160
Drug: Ultrasound-guided core
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ultrasound-guided core needle biopsy (CNB) in patients undergoing antiplatelet/anticoagulation therapy
Trial: 28370160
Drug: Ultrasound-guided core
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ultrasound-guided core needle biopsy (CNB) in patients not undergoing antiplatelet/anticoagulation therapy
Trial: 25481918
Drug: 21-mg nicotine
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 21-mg nicotine patch
Trial: 11106218
Drug: 15-mg nicotine
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 15-mg nicotine patch
Trial: 21364138
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide gas
Trial: 26431718
Drug: Inhaled nitrogen
RxNorm normalized name: nitrogen Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitrogen placebo
Trial: 22665104
Drug: Early invitation
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early invitation with MMS (multiple micronutrients including 30 mg of iron and 400 μg of folic acid)
Trial: 22665104
Drug: Usual invitation
RxNorm normalized name: BERGAMOT,IMITATION
DrugBank: Bergamot oil (DB14335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual invitation with 60 mg of iron and 400 μg of folic acid
Trial: 8544154
Drug: Iso-osmotic bowel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iso-osmotic bowel preparation (Klean Prep)